Denver7 compiles a list of some fun events you might enjoy. Here are our picks for the 7 best things to do in the Denver ...

Madrigal Pharma has become the first drugmaker to claim FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH), an elusive target that has seen many other ...

Madrigal Pharmaceuticals, Inc. Common Stock is estimated to report earnings on 08/06/2025. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates.